MONICA HERRERA: Open Payments
NPI 1033981147 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,844 in 104 payments from 24 companies in 2025. Trend: 2023 $183 · 2024 $2,104 · 2025 $3,844
Food & beverage: $2,810Travel & lodging: $843Education: $190
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $1,209 |
| UCB, Inc. | 32 | $811 |
| GENZYME CORPORATION | 7 | $387 |
| Janssen Biotech, Inc. | 11 | $287 |
| ABBVIE INC. | 13 | $244 |
| Arcutis Biotherapeutics, Inc. | 3 | $204 |
| Amgen Inc. | 5 | $94 |
| Organon LLC | 5 | $89 |
| Regeneron Healthcare Solutions, Inc. | 2 | $77 |
| Incyte Corporation | 3 | $69 |
Products named: Rhapsido, Bimzelx, DUPIXENT, TREMFYA, Zoryve, RINVOQ, OTEZLA, OPZELURA.
Industry payments across GA — which companies pay providers there.
